You are here

Article info

Article menu
Download PDFPDF
Colon
Original article
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis

Authors

  • Hui Ling Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Karen Pickard Cancer Research UK Centre, University of Southampton Cancer Sciences Unit, Somers Cancer Research Building, University Hospital Southampton NHS Foundation Trust, Southampton, UK PubMed articlesGoogle scholar articles
  • Cristina Ivan Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Claudio Isella Department of Oncology, University of Torino, Torino, Italy IRCC, Institute for Cancer Research and Treatment, Candiolo, Torino, Italy PubMed articlesGoogle scholar articles
  • Mariko Ikuo Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Laboratory of Microbiology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Richard Mitter Bioinformatics Unit, London Research Institute, Cancer Research UK, London, UK PubMed articlesGoogle scholar articles
  • Riccardo Spizzo Division of Experimental Oncology 2, CRO, National Cancer Institute, Aviano, Italy PubMed articlesGoogle scholar articles
  • Marc D Bullock Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Cancer Research UK Centre, University of Southampton Cancer Sciences Unit, Somers Cancer Research Building, University Hospital Southampton NHS Foundation Trust, Southampton, UK PubMed articlesGoogle scholar articles
  • Cornelia Braicu Department of Functional Genomics, The Oncology Institute, Cluj-Napoca, Romania PubMed articlesGoogle scholar articles
  • Valentina Pileczki Department of Functional Genomics, The Oncology Institute, Cluj-Napoca, Romania PubMed articlesGoogle scholar articles
  • Kimberly Vincent Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Martin Pichler Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Division of Oncology, Medical University of Graz, Graz, Austria PubMed articlesGoogle scholar articles
  • Verena Stiegelbauer Division of Oncology, Medical University of Graz, Graz, Austria PubMed articlesGoogle scholar articles
  • Gerald Hoefler Institute of Pathology, Medical University of Graz, Graz, Austria PubMed articlesGoogle scholar articles
  • Maria I Almeida Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA INEB, Instituto de Engenharia Biomedica, University of Porto, Porto, Portugal PubMed articlesGoogle scholar articles
  • Annie Hsiao Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Xinna Zhang Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • John N Primrose Cancer Research UK Centre, University of Southampton Cancer Sciences Unit, Somers Cancer Research Building, University Hospital Southampton NHS Foundation Trust, Southampton, UK Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK PubMed articlesGoogle scholar articles
  • Graham K Packham Cancer Research UK Centre, University of Southampton Cancer Sciences Unit, Somers Cancer Research Building, University Hospital Southampton NHS Foundation Trust, Southampton, UK PubMed articlesGoogle scholar articles
  • Kevin Liu Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Krishna Bojja Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Roberta Gafà Section of Pathology and Molecular Diagnostics, University of Ferrara, Ferrara, Italy PubMed articlesGoogle scholar articles
  • Lianchun Xiao Division of Quantitative Science, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Simona Rossi Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Jian H Song Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Ivan Vannini Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) s.r.l., IRCCS, Gene Therapy Unit, Meldola (FC), Italy PubMed articlesGoogle scholar articles
  • Francesca Fanini Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) s.r.l., IRCCS, Gene Therapy Unit, Meldola (FC), Italy PubMed articlesGoogle scholar articles
  • Scott Kopetz Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Patrick Zweidler-McKay Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Xuemei Wang Division of Quantitative Science, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Calin Ionescu Surgical Clinic 1, Cluj County Hospital, Romania UMF Surgery Department 1, Cluj-Napoca, Romania PubMed articlesGoogle scholar articles
  • Alexandru Irimie Department of Surgical and Gynecology Oncology, University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania PubMed articlesGoogle scholar articles
  • Muller Fabbri Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) s.r.l., IRCCS, Gene Therapy Unit, Meldola (FC), Italy Departments of Pediatrics, and Molecular Microbiology and Immunology, University of Southern California, Keck School of Medicine, The Saban Research Institute, Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Giovanni Lanza Section of Pathology and Molecular Diagnostics, University of Ferrara, Ferrara, Italy PubMed articlesGoogle scholar articles
  • Stanley R Hamilton Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Ioana Berindan-Neagoe Department of Functional Genomics, The Oncology Institute, Cluj-Napoca, Romania Department of Immunology and Research Center for Functional Genomics, Biomedicine and Translational Medicine University of Medicine and Pharmacy ‘I. Hatieganu’, Cluj-Napoca, Romania PubMed articlesGoogle scholar articles
  • Enzo Medico Department of Oncology, University of Torino, Torino, Italy IRCC, Institute for Cancer Research and Treatment, Candiolo, Torino, Italy PubMed articlesGoogle scholar articles
  • Alex H Mirnezami Cancer Research UK Centre, University of Southampton Cancer Sciences Unit, Somers Cancer Research Building, University Hospital Southampton NHS Foundation Trust, Southampton, UK Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK PubMed articlesGoogle scholar articles
  • George A Calin Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Milena S Nicoloso Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Division of Experimental Oncology 2, CRO, National Cancer Institute, Aviano, Italy PubMed articlesGoogle scholar articles
  1. Correspondence to Dr George A Calin, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; gcalin{at}mdanderson.org Milena S Nicoloso, MD, Division of Experimental Oncology B, CRO, National Cancer Institute, Aviano, Italy; mnicoloso{at}cro.it Alex Mirnezami, MD, PhD, Cancer Research UK Centre, University of Southampton Cancer Sciences Division, Somers Cancer Research Building, Southampton University Hospital NHS Trust, Tremona road, Southampton, SO16 6YD, UK; A.H.Mirnezami{at}soton.ac.uk.
View Full Text

Citation

Ling H, Pickard K, Ivan C, et al
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis
Gut 2016;65:977-989.

Publication history

  • Received February 11, 2015
  • Revised February 24, 2015
  • Accepted February 26, 2015
  • First published March 24, 2015.
Online issue publication 
October 26, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/